Images List Premium Download Classic

Platelet

Platelet-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Detection of restensosis risk in patients receiving a stent
October 12, 2017 - N°20170292965

Provided is a method of selecting a stent for implantation in the circulatory system of a human being. The method comprises obtaining a blood sample from a patient who requires implantation of a stent and testing said blood sample to determine a platelet coagulability level. The determined platelet coagulability level of said blood sample is compared with a threshold level ...
Optical platelet counter method
Foce Technology International Bv
October 12, 2017 - N°20170292905

Platelets or blood cells are detected in a fluid sample by adjusting a focal depth of a microscope through a range of values, the microscope having a mounted sample and an objective lens adapted with one or both of (a) a spherical aberration correction unmatched to a utilized cover plate for the sample, or (2) a numerical aperture unmatched to a ...
Thermal balancing coating and a manufacturing method thereof
M-victory Specific Material Co., Ltd.
October 12, 2017 - N°20170292027

A manufacturing method for a thermal balancing conductive coating includes steps as: a) providing gluey liquid mixed by a first solution and a compound substance with a weight ratio ranging from 1:0. 6 to 1:1. 4; the compound substance is selected from a group consisting of fluorocarbon resin, fluororesin, acrylic acid resin, polyurethane, polyurea resin, unsaturated polyester, silicon resin, and mixtures thereof; b) providing ...
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Porous alpha-sic-containing shaped body having a contiguous open pore structure
M-victory Specific Material Co., Ltd.
October 12, 2017 - N°20170291133

The present invention relates to a porous alpha-sic-containing shaped body with a gas-permeable, open-pored pore structure comprising platelet-shaped crystallites which are connected to form an interconnected, continuous skeletal structure, wherein the skeletal structure consists of more than 80 wt.-% alpha-sic, relative to the total weight of sic, a process for producing same and its use as a filter component.
Implantable pump system having a coaxial ventricular cannula
Corwave Sa
October 12, 2017 - N°20170290967

An implantable cardiovascular blood pump system is provided, suitable for use as a left ventricular assist device (lvad) system, having an implantable cardiovascular pump, an extracorporeal battery and a controller coupled to the implantable pump, and a programmer selectively periodically coupled to the controller to configure and adjust operating parameters of the implantable cardiovascular pump. The implantable cardiovascular blood pump ...
Implantable pump system having an undulating membrane
Corwave Sa
October 12, 2017 - N°20170290966

An implantable pump system is provided, suitable for use as a left ventricular assist device (lvad) system, having an implantable pump, an extracorporeal battery and a controller coupled to the implantable pump, and a programmer selectively periodically coupled to the controller to configure and adjust operating parameters of the implantable pump. The implantable pump includes a flexible membrane coupled to ...
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
System and kit for the collection and processing of amniotic fluid and placental aspirate
Creative Medical Technologies, Inc.
October 05, 2017 - N°20170281837

Disclosed is a system for the collection, processing and reuse of amniotic fluid and placental aspirate at a c-section site. The system includes a canister positioned along the vacuum line through which the amniotic fluid and placental aspirate is suctioned. The canister has a coil whereby the heavier cellular components, including stem cells, platelets and growth factors, are separated coincident ...
Methods and kits for measuring von willebrand factor
The Medical College Of Wisconsin, Inc.
September 28, 2017 - N°20170276691

Methods and kits for measuring levels of von willebrand factor function in a sample without using a platelet aggregation agonist, such as ristocetin, comprising recombinant glycoprotein ibα having a combination of g233v, d235y and m239v mutations and an agent to detect a complex between the recombinant glycoprotein ibα and von willebrand factor.
Device and method of extracting high-concentration plasma from whole blood
The Medical College Of Wisconsin, Inc.
September 28, 2017 - N°20170274131

Disclosed are a device and method of extracting high-concentration plasma from whole blood. The device comprises: a first syringe; a centrifugation tube that is connected to the first syringe in order to centrifuge whole blood received in the first syringe; a cap that is connected to the first syringe in order to re-centrifuge plasma collected in the first syringe by ...
Platelet rich plasma formulations and use thereof
The Medical College Of Wisconsin, Inc.
September 28, 2017 - N°20170274015

Compositions for platelet rich plasma (prp) are provided. Generally, these compositions comprise a higher concentration of platelets than whole blood. Concentrations of lymphocytes, monocytes, and neutrophils may be different from concentrations found in whole blood. These compositions may have depressed concentrations of red blood cells and hemoglobin. In some variations, the compositions may be useful to treat damaged connective tissue, ...
Pharmaceutical composition containing ginkgolide b and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation ...
Chengdu Baiyu Pharmaceutical Co., Ltd
September 28, 2017 - N°20170273993

Provided is a pharmaceutical composition containing ginkgolide b and the blood platelet prostaglandin cyclooxygenase inhibitor aspirin, a method for preparation of the pharmaceutical composition and a use thereof. When used together, ginkgolide b and aspirin have a synergistic effect in resisting platelet aggregation.
Permanent magnet, rotary electrical machine, and vehicle
Kabushiki Kaisha Toshiba
September 21, 2017 - N°20170271059

A permanent magnet expressed by a composition formula: rpfeqmrcutco100-p-q-r-t. The magnet comprises: a metal structure including a main phase having a th2zn17 crystal phase and a grain boundary phase. The main phase includes a cell phase having the th2zn17 crystal phase, a cu-rich phase having a cu concentration higher than the cell phase, and a plurality of ...
Therapeutic apac molecule comprising heparin conjugated to a plasma protein
Aplagon Oy
September 21, 2017 - N°20170266299

The invention relates to an anti-thrombotic molecule having both antiplatelet and anticoagulant (apac) activity; its use as a medicament; its selective configuration and use as an anticoagulant and platelet inhibitor, or its selective configuration and use, predominantly, as either an anticoagulant or a platelet inhibitor; and a method for its production.
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Astute Medical, Inc.
September 14, 2017 - N°20170261519

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of tumor necrosis factor receptor superfamily member 8, alpha-fetoprotein, ...
Method for the ex vivo cultivation of oral mucosal epithelial progenitor cells and oral mucosal ...
Chang Gung Memorial Hospital, Linkou
September 14, 2017 - N°20170260505

A method for the ex vivo cultivation of oral mucosal epithelial progenitor cells and oral mucosal epithelial cells includes: subjecting an oral mucosal tissue to an enzymatic digestion treatment with collagenase, so as to obtain cell aggregates which include oral mucosal epithelial progenitor cells and oral mucosal epithelial cells; cultivating the cell aggregates with an amniotic membrane in a serum-free ...
Cell culture media compositions for primary cells
Mayo Foundation For Medical Education And Research
September 14, 2017 - N°20170260496

Platelet lysate compositions and cell culture media compositions for maintaining and/or growing mammalian cells, such as mammalian endothelial cells (ecs) and mammalian endothelial progenitor cells (epcs), in particular human ecs (huecs) and human epcs (huepcs), such as primary huecs and primary huepcs, are provided. The cell culture media compositions contain a basal medium, a platelet lysate and, optionally, one ...
Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
Mayo Foundation For Medical Education And Research
September 14, 2017 - N°20170258839

The present invention relates to new plasma or new platelet-rich plasma preparations, new cell dissociation methods, new cell associations or compositions, a method of preparation thereof, a use thereof, devices for the preparation thereof and preparations containing such a platelet-rich plasma preparation and cell associations or compositions. Specifically, the invention provides plasma or platelet-rich plasma alone or in cell composition ...
Platelet-derived growth factor b mutant, preparation method therefor and use thereof
Institute Of Biotechnology Academy Of Military Medical Sciences P.l.a. China
September 07, 2017 - N°20170253642

Provided are a platelet-derived growth factor b derivative, the encoding nucleic acid molecule thereof, and a vector and host cell having the nucleic acid molecule. Also provided are a preparation method for the mutant, and the use of the mutant in preparing medications for promoting cell division, cell proliferation, wound healing, skin regeneration, bone and tooth defect regeneration, and joint ...
Compositions derived from platelet lysates and uses in vascularization
Emory University
September 07, 2017 - N°20170252411

This disclosure relates to compositions comprising a fibrin polymer produced by mixing platelet lysates with a minimal essential medium and thrombin. Typically, an optimized concentration of a calcium salt is utilized. In certain embodiments, the disclosure contemplates compositions comprising a fibrin polymer made by processes disclosed herein that contains cells, endothelial cells, stem cells, adipose tissue derived stem cell (asc), ...
Viral inactivated biological mixture
Omrix Biopharmaceuticals Ltd.
September 07, 2017 - N°20170252372

The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Astute Medical, Inc.
August 31, 2017 - N°20170248613

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of thymic stromal lymphopoietin, vascular endothelial growth factor ...
Loading